Apply to 22+ accelerator programs funding Biotech startups in Japan. Compare funding, equity, and success rates.
Japan ranks #5 globally for accelerator program quality, with 12 programs per 100,000 businesses—well above the national average.
The region has produced 145 successful accelerator exits valued at over $1B, creating a highly supportive funding environment for new startups.
Applications up 25% YoY with focus on AI and climate tech startups
Increasing competition with new programs launching quarterly
Japan
12 weeks program
Japan
14 weeks program
Japan
12 weeks program
Japan
15 weeks program
Japan
17 weeks program
Japan
14 weeks program
Japan
15 weeks program
Japan
17 weeks program
Japan
14 weeks program
Japan
13 weeks program
Japan
12 weeks program
Japan
12 weeks program
Japan
13 weeks program
Japan
16 weeks program
Japan
12 weeks program
Japan
17 weeks program
Japan
14 weeks program
Japan
14 weeks program
Japan
17 weeks program
Japan
12 weeks program
Japan
16 weeks program
Japan
17 weeks program
Japan accelerator programs typically accept 1-3% of applicants, with top-tier programs like those offering $$125K having even more competitive rates. The key is applying to multiple programs that align with your startup's stage and industry focus.
Most Japan accelerators take between 6-8% equity for their investment and program value. The average in our database is 7%, which includes funding, mentorship, office space, and access to investor networks.
Biotech accelerators in Japan typically prioritize strong technical teams, defensible technology or business models, clear market validation, and founders with deep domain expertise in biotech.
$1M-$100M raises, new VC funds, hot opportunities - Weekly newsletter. Your competitors are already reading it.
🔥 Last week: We covered Sequoia's new $3B fund, 12 YC startups that raised, and 3 govt grants worth $500K+
Last updated: 4/4/2026 | Data sources: Program websites, Crunchbase, accelerator reports |About our data